President Trump Launches TrumpRx, Promising Lower Drug Prices: Is It Legit?
20h ago•
bullish:
0
bearish:
0
Share

The White House is betting that a new cash-pay platform—built around blockbuster GLP-1 drugs—can pressure Big Pharma and bypass the middlemen who keep U.S. prices high.
20h ago•
bullish:
0
bearish:
0
Share
Securely connect the portfolio you’re using to start.
